MedTrace Logo

Early Detection of Cardiovascular Disease

NCT03466255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 610

Last updated 2022-06-09

No results posted yet for this study

Summary

The investigators plan to evaluate the correlation between carotid plaque enhancement on Contrast-enhanced ultrasound (CEUS), significant coronary artery disease (CAD), and cardiovascular (CV) outcomes in a systematic manner. The investigators hypothesize that increased levels of CEUS-detected vulnerable carotid plaque will be predictive of CV risk determined by angiography and future cardiovascular events.

Conditions

Interventions

OTHER

Ultrasound

Contrast-enhanced ultrasound (CEUS)

Sponsors & Collaborators

  • Lantheus Medical Imaging

    collaborator INDUSTRY

  • Dr. Amer Johri

    lead OTHER

Principal Investigators

  • Amer M Johri, MD · Queen's University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-06
Primary Completion
2021-06-08
Completion
2022-01-11

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03466255 on ClinicalTrials.gov